Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of 26,179. The enterprise value is 152,669.
| Market Cap | 26,179 |
| Enterprise Value | 152,669 |
Important Dates
The next estimated earnings date is Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Filament Health has 261.79 million shares outstanding. The number of shares has increased by 14.60% in one year.
| Current Share Class | 261.79M |
| Shares Outstanding | 261.79M |
| Shares Change (YoY) | +14.60% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.15% |
| Owned by Institutions (%) | n/a |
| Float | 110.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.05 |
| EV / Sales | 0.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.16 |
Financial Position
The company has a current ratio of 0.30, with a Debt / Equity ratio of 0.98.
| Current Ratio | 0.30 |
| Quick Ratio | 0.30 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.38 |
| Interest Coverage | -17.48 |
Financial Efficiency
Return on equity (ROE) is -272.16% and return on invested capital (ROIC) is -96.18%.
| Return on Equity (ROE) | -272.16% |
| Return on Assets (ROA) | -54.69% |
| Return on Invested Capital (ROIC) | -96.18% |
| Return on Capital Employed (ROCE) | -274.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 13 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8,739 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.62% in the last 52 weeks. The beta is 0.77, so Filament Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -99.62% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 31.31 |
| Average Volume (20 Days) | 47,282 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.72 |
Income Statement
In the last 12 months, Filament Health had revenue of 329,200 and -2.95 million in losses. Loss per share was -0.01.
| Revenue | 329,200 |
| Gross Profit | 329,200 |
| Operating Income | -2.12M |
| Pretax Income | -2.96M |
| Net Income | -2.95M |
| EBITDA | -2.13M |
| EBIT | -2.12M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 242,002 in cash and 368,490 in debt, giving a net cash position of -126,488 or -0.00 per share.
| Cash & Cash Equivalents | 242,002 |
| Total Debt | 368,490 |
| Net Cash | -126,488 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 377,134 |
| Book Value Per Share | 0.00 |
| Working Capital | -884,605 |
Cash Flow
In the last 12 months, operating cash flow was -963,461 and capital expenditures -1,962, giving a free cash flow of -965,423.
| Operating Cash Flow | -963,461 |
| Capital Expenditures | -1,962 |
| Free Cash Flow | -965,423 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -643.17% |
| Pretax Margin | -898.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.60% |
| Shareholder Yield | -14.60% |
| Earnings Yield | -11,259.53% |
| FCF Yield | -3,687.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Filament Health has an Altman Z-Score of -20.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -20.04 |
| Piotroski F-Score | 1 |